ZebiAI is a private biotech developing a powerful new platform to leverage DNA- encoded libraries with ML to accelerate the identification and development of small molecule therapeutics. The company raised a substantial series A with participation from Google Ventures and was subsequently acquired by Relay Therapeutics.
In 2021, Occam placed Brian Goldman, PhD, as SVP & Chief Computation Officer of Zebi. Goldman brings almost thirty years of experience in algorithms and software for molecular modeling, cheminformatics, medicinal chemistry, and image analysis.
